Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1992-4-21
|
pubmed:abstractText |
10 patients (6 females and 4 males with an average age of 75 years) with stable angina pectoris were treated transdermally with mepindolol in a balanced, randomized, controlled, crossover study to compare the anti-ischemic effects of 12-hour overnight, and 24-hour applications. The number of angina pectoris attacks, the oral nitrate consumption and the ischemic parameters in 24-hour ECG, i.e. episodes of manifest (MMI) and silent (SMI) myocardial ischemia, the total duration of ischemia and 24-hour heart rate profiles were investigated. Both application schemes showed typical systemic beta blocker effects in all patients and significant clinical efficacy. A dose/effect relationship and a time/effect relationship between the two different application schemes were demonstrated across all the parameters investigated. Systemic and local tolerance of the therapy was good. 2 patients showed transient, mild skin irritation, but only during one phase of the study. Premature discontinuation was not necessary in any cases. There were no relevant changes in the clinical-chemistry. The new therapeutic concept of 24-hour treatment for a. pectoris with 12-hour overnight transdermal applications showed both good clinical efficacy and a good safety profile.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0174-4879
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
425-30
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1800388-Administration, Cutaneous,
pubmed-meshheading:1800388-Aged,
pubmed-meshheading:1800388-Aged, 80 and over,
pubmed-meshheading:1800388-Angina Pectoris,
pubmed-meshheading:1800388-Blood Pressure,
pubmed-meshheading:1800388-Coronary Disease,
pubmed-meshheading:1800388-Electrocardiography,
pubmed-meshheading:1800388-Female,
pubmed-meshheading:1800388-Heart Rate,
pubmed-meshheading:1800388-Humans,
pubmed-meshheading:1800388-Male,
pubmed-meshheading:1800388-Nitroglycerin,
pubmed-meshheading:1800388-Pindolol,
pubmed-meshheading:1800388-Skin Absorption
|
pubmed:year |
1991
|
pubmed:articleTitle |
Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application.
|
pubmed:affiliation |
Int. Medicine Dept., St. Elisabeth Spital, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|